期刊文献+

E2F-1、E2F-3在膀胱癌组织的表达及临床意义 被引量:2

Expression and clinical significance of E2F-1 and E2F-3 in bladder carcinoma
下载PDF
导出
摘要 目的:探讨膀胱癌转录因子E2F-1、E2F-3的表达及临床意义。方法:应用免疫组织化学方法检测39例膀胱癌与12例正常膀胱粘膜中E2F-1、E2F-3的表达,以统计学方法分析其表达与肿瘤分级、分期、复发之间的关系。结果:E2F-1在膀胱癌组织与正常膀胱粘膜中的阳性表达率分别为82.1%(32/39)和41.7%(5/12),差异有统计学意义(P<0.05)。癌组织E2F-1的表达在不同的临床病理特征之间差异无显著性;E2F-3在膀胱癌组织与正常膀胱粘膜中的阳性表达率分别为53.8%(21/39)和91.7%(11/12),差异有显著性(P<0.05)。癌组织中E2F-3的表达在不同的分级、分期之间差异有显著性(P<0.05)。结论:E2F的异常表达参与膀胱癌的发病过程,并可在一定程度上反映肿瘤的恶性程度。 Objective:To study the expression and clinical significance of E2F-1 and E2F-3 in bladder carcinoma. Methods: Immunohistochemistry staining was used to detect the expression of E2F-1 and E2F-3 in 39 cases of bladder carcinoma and 12 normal bladder tissues. Statistics was used to analyze the data. Results: The positive expression rate of E2F- 1 in cancer tissues was 82.1 % (32/39), which was significantly higher than 41.7 % (5/12) in normal bladder tissue ( P 〈0. 05). The expression of E2F-1 in carcinoma tissues was not correlated with tumor grade, stage and recurrence ( P 〈0.05). The positive expression rate of E2F-3 in cancer tissues was 53.8% (21/ 39), which was significantly lower than 91.7%(11/12) in normal bladder tissue ( P 〈0.05). The expression of E2F-3 was closely associated with tumor grade and stage (p〈0. 05). Conclusions: Aberrant expression of E2F may play an important role in development and progression of bladder carcinoma, and can be used in predicting tumor malignancy.
出处 《临床泌尿外科杂志》 2007年第1期60-62,共3页 Journal of Clinical Urology
关键词 膀胱肿瘤 免疫组织化学 肿瘤标记物 Bladder neoplasm Immunohistochemistry E2F
  • 相关文献

参考文献9

  • 1De Bruin A, Maiti B, Jakoi L, et al. Identification and characterization of E2F7,a novel mammalian E2F family member capable of blocking cellular proliferation[J].J Biol Chem, 2003, 278(43) : 42041--42049.
  • 2Harbour J W, Dean D C. The Rb/E2F pathway: expanding roles and emerging paradigms[J]. Genes Dev,2000 ,14(19) :2393--2409.
  • 3Yasui W, Naka K, Suzuki T , et al. Expression of p27Kipl , cyclin E and E2F2-1 in primary and metastatic tumors of gastric carcinoma [J]. Oncol Rep ,1999 , 6 : 983--987.
  • 4Stanbrough M, Bubley G J, Ross K, et al. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer[J]. Cancer Res, 2006 ,66(5) :2815--2825.
  • 5Krek W, Xu G, Livingston D M. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies sup-pression of a S phase checkpoint[J]. Cell, 1995, 83(7): 1149--1158.
  • 6Shu H K, Julin C M, Furman F, et al. Overexpression of E2F-1 in glioma-derived cell lines induces a p53-independent apoptosis that is further enhanced by ionizing radiation[J]. Neuro Oncol , 2000 ,2(1) :16--21.
  • 7Rounbehler R J , Rogers P M, Conti C J , et al . Inactivation of E2F-1 enhances tumorigenesis in a Myc transgenic model[J]. Cancer Res , 2002 ,62(11) :3276--3281.
  • 8Zhang S Y, Liu S C, Johnson D G, et al. E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell line[J]. Cancer Res, 2000, 60:5972 --5976.
  • 9Suzuki T, Yasui W, Yokozaki H, et al. Expression of the E2F family in human gastrointestinal carcinomas[J]. Int J Cancer,1999,81(4) :535--538.

同被引文献12

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部